[ Price : $8.95]
Concerns that political pressure could undermine the U.S. drug approval system intensify this week after a new White House directi...[ Price : $8.95]
FDA plans to unveil a significant shift in how clinical trials are conducted and regulated, announcing major steps to implement re...[ Price : $8.95]
Galaxy Therapeutics has submitted the final module of a PMA for its SEAL device, a treatment designed for patients with wide-neck ...[ Price : $8.95]
CDER's Office of Compliance releases a new annual report showing that it expanded enforcement and oversight activities in 2025.[ Price : $8.95]
FDA raises multiple manufacturing and quality control concerns at a Swiss drug substance facility operated by Lonza Group, followi...[ Price : $8.95]
FDA announces several actions aimed at accelerating the development of treatments for serious mental illness, following a recent e...[ Price : $8.95]
A recent FDA Warning Letter signals a broader regulatory focus on how drugmakers use artificial intelligence, according to a new a...[ Price : $8.95]
FDA issues AbbVie a complete response letter for its BLA for trenibotulinumtoxinE, an investigational, fast-acting botulinum toxin...